Introduction
Smudge cells, or the so-called Gumprecht shadows, are ruptured or damaged leukocytes during the slide preparation of peripheral blood. Smudge cells may also be presented as bare nuclei isolated from the broken cells varying from well-preserved nuclei without cytoplasm, to smudged nuclear materials with the arrangement of strands in a coarse network, and therefore named basket cells. It has been considered that the formation of smudge cells is attributed to one of the artifacts in vitro in preparing the peripheral blood smear, probably because of the fragility of the leukocytes (Gumprecht, 1986; Macdonald et al., 2003) . In case of atypical lymphocytosis such as chronic lymphocytic leukemia or acute leukemic changes, it could be observed that numerous smudge cells presented in the blood film. Recently, it has been suggested that smudge cells are constituted of apoptotic leukocytes dying in circulation, representing the auto-suicide of cells in process (Paydas, 2010) . Further investigation revealed that the percentage of smudge cells could be a prognostic indicator in patients with chronic lymphocytic leukemia (Nowakovski, 2009; Johansson, 2010) . However, the clinical significance of smudge cells in other hematological malignancies, solid tumors or non-malignant diseases remains to be determined. Therefore, we conducted this study to survey the clinical significance of smudge cells in hematological cancers and other disorders.
Materials and Methods
From January to November, 2015, patients who had archived examination of complete blood count and differential count for clinical purpose revealing the presence of smudge cells in the peripheral blood film in Far Eastern Memorial Hospital were selected. The clinical data were requested, including patient age, gender, clinical diagnosis, absolute lymphocyte count, the percentage of smudge cells and the patient outcomes. The percentage of smudge cells was calculated as the ratio of smudged to intact cells plus smudged lymphocytes. The initial data would be adopted when a patient had multiple results concerning the percentage of smudge cells. Patients would be followed up in a 2-month episode individually for the monitoring of co-morbidity and mortality if any.
Statistical analysis was performed using SPSS (version 19.0; SPSS Inc., Chicago, USA) statistical software. All data were expressed as the median (interquartile range; IQR) or case number (percentage). The odds ratio (OR) with 95% confidence interval (CI) was calculated using the unconditional logistic regression model in assessment of the relationship of percentage of smudge cells to patient outcomes in hematological cancers and other diseases. The cut-off value of the percentage of smudge cells was determined using the integral number near the median of each disease in categorization. The survival analysis was executed using Kaplan-Meier method with log-rank test. Statistical significance was considered if a P value was less than 0.05.
Results
During the study episode, a total of 102 patients who were found to have smudge cells in the peripheral blood smear at Far Eastern Memorial Hospital were enrolled. The demographic features of these subjects were listed in Table 1 . Among these, 30 (29.4%) were admitted due to out-of-hospital cardiac arrest (OHCA), 23 (22.5%) were hematological malignancies and another 23 (22.5%) had infections, 10 (9.8%) had solid cancers and 16 (15.7%) belonged to miscellaneous. The median of absolute lymphocyte count was 4.3 (1.6-6.9) x10 3 / uL in all diseases, 5.5 (2.6-6.8) x10
3 /uL in OHCA, 2.5 (0.9-10.1) x10 3 /uL in all cancers, 3.5 (1.2-11.6) x10 3 /uL in hematological cancers, and 5.0 (1.8-9.4) x10 3 /uL in infections, respectively. The absolute lymphocyte count was seemingly higher in OHCA and infections and lower in cancer groups, but with no statistical significance. Besides, the median percentage of smudge cells was 34.5 (22-55) % in all diseases, 25.5 (19-34) % in OHCA, 54 (29.5-67) % in all cancers, 50 (28-71) % in hematological malignancies, and 34 (22-46) % in infections, respectively. Eventually, the overall 2-month mortality was 34.3% in patients who had smudge cells in the blood film.
Univariate analysis for the percentage of smudge cells and patient outcomes in those with smudge cells in the peripheral blood smear were shown in :http://dx.doi.org/10.7314/APJCP.2016.17.4 
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OR could not be calculated in patients with hematological cancers and infections because there was no death with the percentage of smudge cells less than 50% in hematological malignancies and with the percentage of smudge cells more than 30% in infections. Figure 1 revealed the survival analysis of the percentage of smudge cells and patient outcomes in those with smudge cells in the peripheral blood smear in all diseases, OHCA and all cancers. There was no significant difference between the groups with smudge cells of 30% or more and less than 30% in all diseases (P=0.956, Figure 1A ) and OHCA (P=0.437, Figure 1B) , respectively. Additionally, it was seemingly that patients with smudge cells of 50% or more had a lower survival rate than those with smudge cells less than 50% in all cancers with follow-up in a 2-month interval, but with no statistical significance (P=0.064, Figure 1C ).
Discussion
Our main finding indicated that smudge cells in the peripheral blood smear were frequently presented in OHCA, infections, hematological and solid cancers. It was shown that patients in all cancers with the percentage of smudge cell less than 50% had lower mortality rate when compared with those who had the percentage of smudge cells of 50% or more. Besides, it was seemingly that patients with smudge cells of 50% or more had a lower survival rate than those with smudge cells less than 50% in all cancers with follow-up in a 2-month interval. No apparent difference was found between the groups with smudge cells of 30% or more and less than 30% in all diseases and OHCA, respectively.
According to the literature review, smudge cells were prone to be observed in hematological malignancies, especially in chronic lymphocytic leukemia (Heinivaara et al., 1959; Nosanchuk et al., 1979; Paydas et al., 1999; Khandelwal et al., 2006; Carulli et al., 2007) , although the presence of smudge cells had been considered as a well-described artifact before because of the rupture of fragile lymphocytes in preparing the peripheral blood smear (Macdonald et al., 2003) . It was reported that a remarkable reduction in the percentage of smudge cells was found with the supplement of bovine serum albumin compared with those without (Lunning et al., 2004) . Theoretically, the higher serum concentration of albumin should subsequently lead to less formation of smudge cells (Go et al., 2009 ). However, the association of percentage of smudge cells with serum albumin concentration of patients with chronic lymphocytic leukemia remained ascertained. Besides, accumulating evidence revealed that the percentage of smudge cells could be an independently prognostic indicator in patients with chronic lymphocytic leukemia (Nowakowski et al., 2009; Johansson et al., 2010; Gogia et al., 2014) . In brief, it was shown that patients with more than 30% of smudge cells had a better overall survival rate than those with 30% or less smudge cells in chronic lymphocytic leukemia. Additionally, it was indicated that a high content of vimentin, one of the cytoskeletal proteins indispensable for the rigidity and integrity of lymphocytes, was significantly associated with lower percentage of smudge cells, as well as with a shortened interval to initial therapy in the early stage of chronic lymphocytic leukemia (Nowakowski et al., 2005) . Further studies disclosed that there was an inverse correlation of the percentage of smudge cells with the presence of CD38, CD45 and zeta associated protein (ZAP)-70, which was also found to be independently prognostic factors for chronic lymphocytic leukemia (Nowakowski et al., 2007; Xu et al., 2009; Paydas, 2010; Zaher et al., 2011; Szerafin et al., 2012) . The mutational status of immunoglobulin heavy chain and specific chromosomal aberrancies such as trisomy 12, 11q or 17p deletions were also considered as poor prognostic indicators for chronic lymphocytic leukemia (Wierda et al., 2011; Rizzo et al., 2013; Trajkova et al., 2013; Strati al., 2014) . In contrast, another study showed that there was no apparent correlation between the percentage of smudge cells in peripheral blood film and the prognosis of patients with chronic lymphocytic leukemia (Mozaheb et al., 2012) . Interestingly, our investigation showed quite different results in which patients in all cancers with 50% or more smudge cells, including leukemias, had worse outcomes when compared with those with less than 50% of smudge cells in the peripheral blood smear. However, the underlying causes and mechanisms remained to be elucidated. One possible explanation to this discrepancy could be the divergence of race-ethnicity, since most of the study populations were non-Asian, in which patients diagnosed as chronic lymphocytic leukemia had better outcomes with higher percentage of smudge cells in the peripheral blood film. Therefore, a large-scale prospective study should be conducted to determine the prognostic role of smudge cells accompanied with the nutrition status in chronic lymphocytic leukemia, particularly in the Asian populations.
The presence of smudge cells in the blood film was also found in patients with OHCA and infections in our study. There was no obvious association of the percentage of smudge cells with the mortality or outcomes in perspective of all diseases, OHCA or all cancers. Whether the presence of smudge cells was related to the diseases rather than chronic lymphocytic leukemia remained ascertained.
The major limitation of our investigation was the retrospective study design with the limited subject number. Besides, the nutrition status was not available in the study population, making it difficult to differentiate the source of smudge cells formation from the categorized diseases per se or inappropriate preparation of blood film. Furthermore, the monitor interval could not be adequate enough to observe the disease evolution as well as the complication events and long-term mortality in certain disease categorizations, thus suggesting inevitable bias to some extents.
In summary, our study showed that in all cancers, those who had higher percentage of smudge cells were prone to have poor outcomes when compared with the subjects with lower percentage of smudge cells in the blood smear. This finding was quite different from the results of previous studies in which the race-ethnicity of most study populations was non-Asian. Hence, the clinical significance of smudge cells in malignancies remained indeterminate and further investigations were required. Besides, there was no apparent association of the percentage of smudge cells with patient outcomes in all diseases and OHCA, respectively.
